At a glance
- Originator GlaxoSmithKline
- Class Antivirals; Lactams; Pyrrolidines; Small molecules
- Mechanism of Action Hepatitis C virus NS3 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 04 Mar 2008 Discontinued - Preclinical for Hepatitis C in United Kingdom (unspecified route)
- 18 Sep 2002 Preclinical trials in Hepatitis C in United Kingdom (unspecified route)